<VariationArchive RecordType="classified" VariationID="12042" VariationName="NM_001018115.1:c.1414_1545del" VariationType="Deletion" Accession="VCV000012042" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-09-16" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="27081" VariationID="12042">
      <GeneList>
        <Gene Symbol="FANCD2" FullName="FA complementation group D2" GeneID="2177" HGNC_ID="HGNC:3585" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>3p25.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="10026437" stop="10101932" display_start="10026437" display_stop="10101932" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="10068112" stop="10143613" display_start="10068112" display_stop="10143613" Strand="+" />
          </Location>
          <OMIM>613984</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001018115.1:c.1414_1545del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p25.3</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>EX17 DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_306t1" sequenceAccession="LRG_306t1">
            <Expression>LRG_306t1:c.1414_1545del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="613984.0005" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="GenomicLocationNotEstablished">The genomic location for this variant will not be computed from alignment of the transcript sequence to the genome until there is experimental evidence for the genomic basis for the loss of exon 17 from the cDNA.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001018115.1:c.1414_1545del AND Fanconi anemia complementation group D2" Accession="RCV000012822" Version="2">
        <ClassifiedConditionList TraitSetID="3251">
          <ClassifiedCondition DB="MedGen" ID="C3160738">Fanconi anemia complementation group D2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2001-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2001-02-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11239453</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3251" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10926" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Fanconi anemia complementation group D2</ElementValue>
                <XRef ID="MONDO:0009214" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">FANCONI PANCYTOPENIA, TYPE 4</ElementValue>
                <XRef Type="MIM" ID="227646" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">FANCONI ANEMIA, COMPLEMENTATION GROUP D</ElementValue>
                <XRef Type="MIM" ID="227646" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FA4</ElementValue>
                <XRef Type="MIM" ID="227646" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FANCD</ElementValue>
                <XRef Type="MIM" ID="227646" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FANCD2</ElementValue>
                <XRef Type="MIM" ID="227646" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FACD</ElementValue>
                <XRef Type="MIM" ID="227646" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FAD2</ElementValue>
                <XRef Type="MIM" ID="227646" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Fanconi anemia (FA) is characterized by physical abnormalities, bone marrow failure, and increased risk for malignancy. Physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and/or lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies. Progressive bone marrow failure with pancytopenia typically presents in the first decade, often initially with thrombocytopenia or leukopenia. The incidence of acute myeloid leukemia is 13% by age 50 years. Solid tumors – particularly of the head and neck, skin, and genitourinary tract – are more common in individuals with FA.</Attribute>
                <XRef ID="NBK1401" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301575</ID>
                <ID Source="BookShelf">NBK1401</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="FARF, 2008">
                <URL>http://www.fanconi.org/images/uploads/other/Guidelines_for_Diagnosis_and_Management.pdf</URL>
                <CitationText>Fanconi Anemia Research Fund, Guidelines for Diagnosis and Management, 2008 (See 2020 Update)</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="FARF, 2020">
                <URL>https://www.fanconi.org/images/uploads/other/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.pdf</URL>
                <CitationText>Fanconi Anemia Clinical Care Guidelines, Fifth Edition.</CitationText>
              </Citation>
              <XRef ID="84" DB="Orphanet" />
              <XRef ID="C3160738" DB="MedGen" />
              <XRef ID="MONDO:0009214" DB="MONDO" />
              <XRef Type="MIM" ID="227646" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="33062" SubmissionDate="2012-10-24" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="613984.0005_FANCONI ANEMIA, COMPLEMENTATION GROUP D2" title="FANCD2, EX17 DEL_FANCONI ANEMIA, COMPLEMENTATION GROUP D2" />
        <ClinVarAccession Accession="SCV000033062" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In the PD733 cell line from a patient with Fanconi anemia complementation group D2 (227646), Timmers et al. (2001) identified by RT-PCR the absence of exon 17 of FANCD2 causing an internal deletion of the protein. The genomic alteration in this patient was not found. PD733 did not express any FANCD2 protein.</Attribute>
              <Citation>
                <ID Source="PubMed">11239453</ID>
              </Citation>
              <XRef DB="OMIM" ID="227646" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FANCD2" />
          </GeneList>
          <Name>FANCD2, EX17 DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">EX17 DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="613984.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">FANCONI ANEMIA, COMPLEMENTATION GROUP D2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="33062" TraitType="Disease" MappingType="Name" MappingValue="FANCONI ANEMIA, COMPLEMENTATION GROUP D2" MappingRef="Preferred">
        <MedGen CUI="C3160738" Name="Fanconi anemia complementation group D2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

